Serum Institute of India Pvt. Ltd.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Serum Institute of India Pvt. Ltd.
India’s interim budget 2024 hikes allocation for production-linked incentive schemes in pharmaceuticals, supports biotech start-ups - particularly green ones- and sets the right note for inclusion of HPV vaccination in the country’s Universal Immunization Program, one of the world's largest public health programs. How does it help?
A mention in India’s interim budget of support for HPV vaccination is heartening for Serum Institute and Merck as it is seen as a precursor to the vaccine’s inclusion in the country’s Universal Immunization Program, one of the largest public health programs globally. As Serum plans to expand capacity, will Merck drop Gardasil prices for a piece of the UIP pie?
Zydus is developing a novel ADC, one of the most challenging but rewarding treatment modalities today as others in the class like Kadcyla and Enhertu prove. The Indian firm's managing director spoke to Scrip about R&D efforts, recent policy moves and gains from making the world’s first approved recombinant plasmid DNA vaccine.
MSD India managing director Rehan Khan shares with Scrip glimpses of his life and professional journey, including diversity, equity and inclusion values imbibed in his childhood, co-founding an early-stage venture fund, widening access to Keytruda to roughly “six times more patients” in the country and initiatives around HPV vaccination.
- Large Molecule
- Other Names / Subsidiaries
- Bilthoven Biologicals
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.